Table 5.
Pathology characteristics | Number of samples | Positive (%) | Negative (%) | P value | |
---|---|---|---|---|---|
Neoadjuvant chemotherapy | Yes | 40 | 35(87.50%) | 5(12.50%) | <0.010* |
No | 32 | 14(43.75%) | 18(56.25%) | ||
Differentiation | Low differentiation | 12 | 9(75.00%) | 3(25.00%) | 0.344 |
High differentiation | 40 | 24(60.00%) | 16(40.00%) | ||
Pathological stage | I-IIa | 61 | 38(62.30%) | 23(37.70%) | 0.0199* |
IIb-IV | 20 | 18(90.00%) | 2(10.00%) | ||
Lymph node metastasis | Yes | 18 | 15(83.33%) | 3(16.67%) | 0.039* |
No | 60 | 37(61.67%) | 23(38.33%) | ||
Vascular invasion | Yes | 13 | 11(84.62%) | 2(15.38%) | 0.046* |
No | 55 | 30(54.55%) | 25(45.45%) |
* represents P<0.05.